版本:
中国

BRIEF-Bausch + Lomb Canada launches bepreve 1.5 pct w/v for allergic conjunctivitis

March 22 Valeant Pharmaceuticals International Inc:

* Bausch + Lomb - Bausch + Lomb Canada launches bepreve (bepotastine besilate ophthalmic solution) 1.5 pct w/v for allergic conjunctivitis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐